(Q44769045)

6 December 2017

0 references

Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer prevention (English)

1 reference

6 December 2017

1 reference

1 reference

1

1 reference

6 December 2017

language of work or name

1 reference

1 January 2009

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

6 December 2017

published in

1 reference

6 December 2017

volume

9

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

1-6

1 reference

A second generation human haplotype map of over 3.1 million SNPs

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

A HapMap harvest of insights into the genetics of common disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

Breakthrough of the year. Human genetic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

Expectations and challenges stemming from genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

Replicating genotype-phenotype associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

Gastric cancer in Japan--honing treatment, seeking causes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

Current status and future perspectives in gastric cancer management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

E-cadherin germline mutations in familial gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

Familial gastric cancer - aetiology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

Genome-wide association study identifies novel breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

Letting the genome out of the bottle--will we get our wish?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

Nutrition and gastric cancer risk: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

Identification of ALK as a major familial neuroblastoma predisposition gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1586%2F14737159.9.1.1

21 January 2018

Identifiers

DOI

10.1586/14737159.9.1.1

1 reference

6 December 2017

1 reference